Medtronic InFuse Sales Flat In Q2; Firm’s Spine Business Still Struggling

Medtronic is exploring alternative distribution channels in oral maxillofacial and trauma markets to grow its struggling InFuse bone graft franchise, the firm said during its Nov. 18 fiscal second-quarter earnings call

More from Archive

More from Medtech Insight